| Miriam R Brown, MD | |
|
509 S Lenola Rd Ste 11a, Moorestown, NJ 08057-1561 | |
| (856) 234-0258 | |
| (856) 727-9518 |
| Full Name | Miriam R Brown |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 31 Years |
| Location | 509 S Lenola Rd Ste 11a, Moorestown, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225035306 | NPI | - | NPPES |
| 0005444 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD067937L (Pennsylvania) | Secondary |
| 207W00000X | Ophthalmology | 25MA07621600 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associated Retinal Consultants Llc | 2961509161 | 114 |
News Archive
The US Food and Drug Administration has approved SonaCare Medical's Sonablate 450 focused ultrasound system for the ablation of prostate tissue. Focused ultrasound enables treatment of organ-confined prostate disease while preserving surrounding healthy tissue, without radiation or surgery.
AstraZeneca and MSD (Merck) announced today that the U.S. Food and Drug Administration (FDA) has granted acceptance to file status of its application for the MEK inhibitor selumetinib, for use in patients with plexiform neurofibromas, a common manifestation in the disease neurofibromatosis type one (NF1).
These guidelines, which increase access to contraceptive services for women while upholding the religious liberty of churches, mosques and synagogues, strike the proper balance between respecting the religious beliefs of all Americans and protecting the health of American women and families. They will reduce health costs, end long-standing gender discrimination in prescription drug coverage and further enable women to lead healthier lives.
HIV-infected patients in the African country of Tanzania were more likely to stop taking their medications and to fail treatment if they had to pay for the drugs themselves.
› Verified 7 days ago
| Entity Name | Associated Retinal Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164578894 PECOS PAC ID: 2961509161 Enrollment ID: O20070523000337 |
News Archive
The US Food and Drug Administration has approved SonaCare Medical's Sonablate 450 focused ultrasound system for the ablation of prostate tissue. Focused ultrasound enables treatment of organ-confined prostate disease while preserving surrounding healthy tissue, without radiation or surgery.
AstraZeneca and MSD (Merck) announced today that the U.S. Food and Drug Administration (FDA) has granted acceptance to file status of its application for the MEK inhibitor selumetinib, for use in patients with plexiform neurofibromas, a common manifestation in the disease neurofibromatosis type one (NF1).
These guidelines, which increase access to contraceptive services for women while upholding the religious liberty of churches, mosques and synagogues, strike the proper balance between respecting the religious beliefs of all Americans and protecting the health of American women and families. They will reduce health costs, end long-standing gender discrimination in prescription drug coverage and further enable women to lead healthier lives.
HIV-infected patients in the African country of Tanzania were more likely to stop taking their medications and to fail treatment if they had to pay for the drugs themselves.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miriam R Brown, MD 509 S Lenola Rd Ste 11a, Moorestown, NJ 08057-1561 Ph: (856) 234-0258 | Miriam R Brown, MD 509 S Lenola Rd Ste 11a, Moorestown, NJ 08057-1561 Ph: (856) 234-0258 |
News Archive
The US Food and Drug Administration has approved SonaCare Medical's Sonablate 450 focused ultrasound system for the ablation of prostate tissue. Focused ultrasound enables treatment of organ-confined prostate disease while preserving surrounding healthy tissue, without radiation or surgery.
AstraZeneca and MSD (Merck) announced today that the U.S. Food and Drug Administration (FDA) has granted acceptance to file status of its application for the MEK inhibitor selumetinib, for use in patients with plexiform neurofibromas, a common manifestation in the disease neurofibromatosis type one (NF1).
These guidelines, which increase access to contraceptive services for women while upholding the religious liberty of churches, mosques and synagogues, strike the proper balance between respecting the religious beliefs of all Americans and protecting the health of American women and families. They will reduce health costs, end long-standing gender discrimination in prescription drug coverage and further enable women to lead healthier lives.
HIV-infected patients in the African country of Tanzania were more likely to stop taking their medications and to fail treatment if they had to pay for the drugs themselves.
› Verified 7 days ago
Cathy Yx Zhang, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 509 S Lenola Rd # 11-a, Moorestown, NJ 08057 Phone: 856-234-0222 | |
Michael Colucciello Iii, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 509 S Lenola Rd Ste 11a, Moorestown, NJ 08057 Phone: 856-234-0258 Fax: 856-727-9518 | |
Amy R Wexler, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 509 S Lenola Rd Ste 11a, Moorestown, NJ 08057 Phone: 856-234-0258 Fax: 856-727-9518 | |
Dr. Trong D Tran, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 509 S Lenola Rd Ste 11a, Moorestown, NJ 08057 Phone: 856-234-0258 Fax: 856-727-9518 | |
Dr. Sharad Sunder Mansukani, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 411 Park Ln, Moorestown, NJ 08057 Phone: 856-234-4382 | |
Dr. Daniel P Putnam, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 509 S Lenola Rd Ste 11a, Moorestown, NJ 08057 Phone: 856-234-0258 Fax: 856-727-9518 |